Skip to main content
Skip to section navigation
Skip to footer
Investors
Investors & Media
News/Events
Company Information
Financial Information
Stock Data
SEC Filings
Governance
Analyst Coverage
Media
Top News
Media Inquiries
Media Resources
Contact
General Inquiries
Join Us
Culture & Values
Join the Team
About Us
Overview
Leadership
Board of Directors
Research Partners & Collaborators
ZEVASKYN
®
ZEVASKYN
Abeona Assist
®
Pipeline & Science
Overview
Manufacturing
Publications & Presentations
Patients
Overview
Patient Stories
Access Policy
Pricing Disclosure
Skip to main content
Skip to section navigation
Skip to footer
chevron_left
Back to CorporateSite.com
About Us
Overview
Leadership
Board of Directors
Research Partners & Collaborators
ZEVASKYN
®
ZEVASKYN
Abeona Assist
®
Pipeline & Science
Overview
Manufacturing
Publications & Presentations
Patients
Overview
Patient Stories
Access Policy
Pricing Disclosure
Investors
Investors & Media
News/Events
Company Information
Financial Information
Stock Data
SEC Filings
Governance
Analyst Coverage
Media
Top News
Media Inquiries
Media Resources
Contact
General Inquiries
Join Us
Culture & Values
Join the Team
chevron_left
Back to CorporateSite.com
Events
Investors
Investors
Investors & Media
News/Events
News / Events Overview
Press Releases
Events
Email Alerts
Company Information
Company Profile
Presentations
Management Team
Contacts
Financial Information
Financial Information Overview
Financial Results
Stock Data
Stock Data Overview
Stock Chart & Detailed Quote
Historical Data
SEC Filings
SEC Filings Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Governance Overview
Board of Directors
Board Committees
Governance Documents
Analyst Coverage
Phase 3 VIITAL™ Clinical Study Topline Results Call
Nov 3, 2022 8:30 am EDT
Presentation
PDF
email
Email Alerts
location_city
Company Profile
contact_page
Contacts
rss_feed
RSS News Feed
accessibility
Accessibility Statement
